Home › Funds › MANGROVE PARTNERS IM, LLC › BIO
MANGROVE PARTNERS IM, LLC position in BIO
BIO RAD LABS INC · Industrials
MANGROVE PARTNERS IM, LLC reported holding 127,117 shares of BIO (BIO RAD LABS INC) in its Q3 2026 13F filing — a position valued at US$48.0M, representing 3.26% of its reported portfolio and ranking #11 among its reported holdings. MANGROVE PARTNERS IM, LLC has disclosed BIO holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How MANGROVE PARTNERS IM, LLC's BIO position evolved
MANGROVE PARTNERS IM, LLC first disclosed a stake in BIO in Q3 2025 at 126,853 shares (US$35.6M). The position peaked in Q3 2026 at 127,117 shares, worth US$48.0M. Across 5 filings, MANGROVE PARTNERS IM, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 127,117 shares valued at US$48.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 126.85K | $35.57M | New |
| Q4 2025 | 126.85K | $38.44M | Hold |
| Q1 2026 | 126.85K | $35.36M | Hold |
| Q2 2026 | 127.19K | $37.34M | Hold |
| Q3 2026 | 127.12K | $48.01M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIO and 13F data
BIO (BIO RAD LABS INC) is a Industrials company. 28 other funds we track also report a position in BIO — the largest reported positions include First Eagle Investment Management (US$927.5M), ARIEL INVESTMENTS, LLC (US$298.1M), EARNEST PARTNERS LLC (US$214.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIO
- First Eagle Investment Management 2.46M sh · $927.50M · Q3 2026
- ARIEL INVESTMENTS, LLC 789.34K sh · $298.14M · Q3 2026
- EARNEST PARTNERS LLC 567.82K sh · $214.47M · Q3 2026
- First Pacific Advisors, LP 269.08K sh · $101.63M · Q3 2026
- NOMURA HOLDINGS INC 328.90K sh · $96.57M · Q2 2026
More on MANGROVE PARTNERS IM, LLC
FAQ
How long has MANGROVE PARTNERS IM, LLC held BIO?
MANGROVE PARTNERS IM, LLC has disclosed BIO holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is MANGROVE PARTNERS IM, LLC's current position in BIO?
As of Q3 2026, MANGROVE PARTNERS IM, LLC holds 127.12K shares of BIO (BIO RAD LABS INC), valued at $48.01M, representing 3.26% of its reported portfolio and ranking #11.
Has MANGROVE PARTNERS IM, LLC been buying or selling BIO?
In the latest 13F filing (Q3 2026), MANGROVE PARTNERS IM, LLC held unchanged its position in BIO. The position peaked in Q3 2026 at 127.12K shares.
Which other funds hold BIO?
Other major institutional holders of BIO include First Eagle Investment Management, ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.